Clinical Trial Update: Intrapleural Fibrinolytic Therapy to Enhance Chemical Pleurodesis Enhance Chemical Pleurodesis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether intrapleural fibrinolytic therapy can enhance the effectiveness of chemical pleurodesis in pleural effusion; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pleural Effusion

Drugs mentioned

• Intrapleural fibrinolytic therapy (fibrinolytic agent)

Snippet

Sponsor: Memorial Healthcare System | Conditions: Pleural Effusion | Phase 4 | Status: COMPLETED | Results posted: 2024-12-11